Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 79

Cited In for PubMed (Select 18535182)

1.

The key role of transient receptor potential melastatin-2 channels in amyloid-β-induced neurovascular dysfunction.

Park L, Wang G, Moore J, Girouard H, Zhou P, Anrather J, Iadecola C.

Nat Commun. 2014 Oct 29;5:5318. doi: 10.1038/ncomms6318.

2.

Aag-initiated base excision repair promotes ischemia reperfusion injury in liver, brain, and kidney.

Ebrahimkhani MR, Daneshmand A, Mazumder A, Allocca M, Calvo JA, Abolhassani N, Jhun I, Muthupalani S, Ayata C, Samson LD.

Proc Natl Acad Sci U S A. 2014 Nov 11;111(45):E4878-86. doi: 10.1073/pnas.1413582111. Epub 2014 Oct 27.

3.

Hyperglycemia as a Risk Factor of Ischemic Stroke.

Zhang Z, Yan J, Shi H.

J Drug Metab Toxicol. 2013 Jun 29;4(4). pii: 153.

4.

Endothelial dysfunction is a potential contributor to multiple organ failure and mortality in aged mice subjected to septic shock: preclinical studies in a murine model of cecal ligation and puncture.

Coletta C, Módis K, Oláh G, Brunyánszki A, Herzig DS, Sherwood ER, Ungvári Z, Szabo C.

Crit Care. 2014 Sep 16;18(5):511. doi: 10.1186/s13054-014-0511-3.

5.

Insulin renders diabetic rats resistant to acute ischemic stroke by arresting nitric oxide reaction with superoxide to form peroxynitrite.

Hung LM, Huang JP, Liao JM, Yang MH, Li DE, Day YJ, Huang SS.

J Biomed Sci. 2014 Sep 16;21:92. doi: 10.1186/s12929-014-0092-0.

6.

The poly(adenosine diphosphate-ribose) polymerase inhibitor PJ34 reduces pulmonary ischemia-reperfusion injury in rats.

Hatachi G, Tsuchiya T, Miyazaki T, Matsumoto K, Yamasaki N, Okita N, Nanashima A, Higami Y, Nagayasu T.

Transplantation. 2014 Sep 27;98(6):618-24. doi: 10.1097/TP.0000000000000305.

7.

PARP-inhibitor treatment prevents hypertension induced cardiac remodeling by favorable modulation of heat shock proteins, Akt-1/GSK-3β and several PKC isoforms.

Deres L, Bartha E, Palfi A, Eros K, Riba A, Lantos J, Kalai T, Hideg K, Sumegi B, Gallyas F, Toth K, Halmosi R.

PLoS One. 2014 Jul 11;9(7):e102148. doi: 10.1371/journal.pone.0102148. eCollection 2014.

8.

Interplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy.

Varga ZV, Giricz Z, Liaudet L, Haskó G, Ferdinandy P, Pacher P.

Biochim Biophys Acta. 2015 Feb;1852(2):232-42. doi: 10.1016/j.bbadis.2014.06.030. Epub 2014 Jul 2. Review.

PMID:
24997452
9.

Poly(ADP-ribose) polymerase-dependent energy depletion occurs through inhibition of glycolysis.

Andrabi SA, Umanah GK, Chang C, Stevens DA, Karuppagounder SS, Gagné JP, Poirier GG, Dawson VL, Dawson TM.

Proc Natl Acad Sci U S A. 2014 Jul 15;111(28):10209-14. doi: 10.1073/pnas.1405158111. Epub 2014 Jul 1.

10.

Modulation of poly(ADP-ribose) polymerase-1 (PARP-1)-mediated oxidative cell injury by ring finger protein 146 (RNF146) in cardiac myocytes.

Gerö D, Szoleczky P, Chatzianastasiou A, Papapetropoulos A, Szabo C.

Mol Med. 2014 Jul 31;20:313-28. doi: 10.2119/molmed.2014.00102.

11.

Parthanatos: mitochondrial-linked mechanisms and therapeutic opportunities.

Fatokun AA, Dawson VL, Dawson TM.

Br J Pharmacol. 2014 Apr;171(8):2000-16. doi: 10.1111/bph.12416. Review.

12.

Mechanisms of neurovascular dysfunction in acute ischemic brain.

Terasaki Y, Liu Y, Hayakawa K, Pham LD, Lo EH, Ji X, Arai K.

Curr Med Chem. 2014;21(18):2035-42. Review.

13.

Accelerated aging during chronic oxidative stress: a role for PARP-1.

Boesten DM, de Vos-Houben JM, Timmermans L, den Hartog GJ, Bast A, Hageman GJ.

Oxid Med Cell Longev. 2013;2013:680414. doi: 10.1155/2013/680414. Epub 2013 Nov 10.

14.

PARP inhibition attenuates acute kidney allograft rejection by suppressing cell death pathways and activating PI-3K-Akt cascade.

Kalmar-Nagy K, Degrell P, Szabo A, Sumegi K, Wittmann I, Gallyas F Jr, Sumegi B.

PLoS One. 2013 Dec 3;8(12):e81928. doi: 10.1371/journal.pone.0081928. eCollection 2013.

15.

Poly (ADP-ribose) polymerase-1 is a key mediator of liver inflammation and fibrosis.

Mukhopadhyay P, Rajesh M, Cao Z, Horváth B, Park O, Wang H, Erdelyi K, Holovac E, Wang Y, Liaudet L, Hamdaoui N, Lafdil F, Haskó G, Szabo C, Boulares AH, Gao B, Pacher P.

Hepatology. 2014 May;59(5):1998-2009. doi: 10.1002/hep.26763. Epub 2014 Apr 1.

16.

Cellular metabolic and autophagic pathways: traffic control by redox signaling.

Dodson M, Darley-Usmar V, Zhang J.

Free Radic Biol Med. 2013 Oct;63:207-21. doi: 10.1016/j.freeradbiomed.2013.05.014. Epub 2013 May 20. Review.

17.

Reduced estradiol-induced vasodilation and poly-(ADP-ribose) polymerase (PARP) activity in the aortas of rats with experimental polycystic ovary syndrome (PCOS).

Masszi G, Horvath EM, Tarszabo R, Benko R, Novak A, Buday A, Tokes AM, Nadasy GL, Hamar P, Benyó Z, Varbiro S.

PLoS One. 2013;8(3):e55589. doi: 10.1371/journal.pone.0055589. Epub 2013 Mar 26. Erratum in: PLoS One. 2014;9(2):e91625.

18.

Therapeutic applications of PARP inhibitors: anticancer therapy and beyond.

Curtin NJ, Szabo C.

Mol Aspects Med. 2013 Dec;34(6):1217-56. doi: 10.1016/j.mam.2013.01.006. Epub 2013 Jan 29. Review.

19.

Crosstalk between poly(ADP-ribose) polymerase and sirtuin enzymes.

Cantó C, Sauve AA, Bai P.

Mol Aspects Med. 2013 Dec;34(6):1168-201. doi: 10.1016/j.mam.2013.01.004. Epub 2013 Jan 25. Review.

20.

Minocycline blocks asthma-associated inflammation in part by interfering with the T cell receptor-nuclear factor κB-GATA-3-IL-4 axis without a prominent effect on poly(ADP-ribose) polymerase.

Naura AS, Kim H, Ju J, Rodriguez PC, Jordan J, Catling AD, Rezk BM, Abd Elmageed ZY, Pyakurel K, Tarhuni AF, Abughazleh MQ, Errami Y, Zerfaoui M, Ochoa AC, Boulares AH.

J Biol Chem. 2013 Jan 18;288(3):1458-68. doi: 10.1074/jbc.M112.419580. Epub 2012 Nov 26.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk